Advancing Psychiatric Practice Through the Science of Addiction
AMERICAN PSYCHIATRIC ASSOCIATION164th Annual Meeting
Honolulu, HI • May 14–18, 2011
A Research Track From theNATIONAL INSTITUTE ON DRUG ABUSE
P A G E 1
P A G E 1
AMERICAN PSYCHIATRIC ASSOCIATION ANNUAL MEETING
Honolulu, Hawaii • May 14–18, 2011
MISSION STATEMENTThe mission of the National Institute on Drug Abuse (NIDA) is to lead the Nation in bringing the power of science to bear on drug abuse and addiction. This charge has two critical components. The first is strategic support and conduct of basic, clinical, and applied research across a broad range of disciplines, ranging from genetics and neurobiology to behavioral and social science. The second is ensuring the rapid and effective dissemination and use of research results to improve prevention and treatment, and inform policy.
EXHIBITA wide variety of materials are available at the NIDA exhibit, at Booth 1030, in the APA Exhibit Hall.
WEBSITEInformation about NIDA research, programs, and events is accessible through NIDA’s website at www.drugabuse.gov.
http://www.drugabuse.gov
P A G E 2 P A G E 3
SATURDAY, MAY 14
8:00 a.m.–11:00 a.m. Symposium (Session #S4)Brain Mechanisms and Neuropsychiatry in Smoking CessationHawaii Convention Center—Room 317A/B, Level 3
Co-Chairs: Geetha Subramaniam, M.D. National Institute on Drug Abuse
Steven Grant, Ph.D. National Institute on Drug Abuse
Presenters: Amy Janes, Ph.D. McLean Hospital Brain Functional Magnetic Resonance Imaging Reactivity and Attentional Bias in Tobacco Abstinence
Richard Yi, Ph.D. University of Maryland, College Park Impulsivity in Smoking Cessation
Benjamin Toll, Ph.D. Yale University School of Medicine Naltrexone in Supplementing Nicotine Replacement Therapy for Smokers
Laura MacPherson, Ph.D. University of Maryland, College Park Behavioral Activation in Depressed Smokers Receiving Nicotine Replacement Therapy
Discussant: Tony George, M.D. University of Toronto
S AT URDAY, M AY 14
P A G E 2 P A G E 3
SUNDAY, MAY 15
8:00 a.m.–11:00 a.m. Symposium (Session #S13)Decision Making and Addictions: Neurobiology and Treatment Implications Hawaii Convention Center—Room 324, Level 3
Co-Chairs: Ivan Montoya, M.D., M.P.H. National Institute on Drug Abuse
Frederick Moeller, M.D. The University of Texas Health Science Center
Presenters: Catharine Winstanley, Ph.D. University of British Columbia Basic Neurobiology of Decision Making
Scott Lane, Ph.D. The University of Texas Health Science Center The Impact of Drugs of Abuse on Decision Making
Warren Bickel, Ph.D.Virginia Tech Carilion Research Institute Neuro-Cognitive and Behavioral Interventions to Improve Addict Decision Making
Frederick Moeller, M.D. The University of Texas Health Science Center Pharmacotherapies for Drug Addiction Aiming at Improving Decision Making
Discussant: Antoine Bechara, Ph.D. University of Southern California
S UNDAY, M AY 15
P A G E 4 P A G E 5
MONDAY, MAY 16
8:00 a.m.–11:00 a.m. Symposium (Session #S36)The Shrinking Psychotherapeutic Pipeline: Why Has the Spigot Been Turned Off? Hawaii Convention Center—Room 316A, Level 3
Co-Chairs: Ivan Montoya, M.D., M.P.H. National Institute on Drug Abuse
Bruce Cuthbert, Ph.D. National Institute of Mental Health
Presenters: Irwin Lucki, Ph.D. University of Pennsylvania Increasing the Validity of Animal Models of Depression by Genetic–Environment Interactions
David Michelson, M.D. Merck and Company New Drugs to No Drugs: Antidepressants and Drug Discovery/Development
Mark Geyer, Ph.D. University of California, San Diego Cross-Species Tests for Cognition Enhancement in Schizophrenia
Lon Schneider, M.D. University of Southern California Keck School of Medicine Alzheimer’s Disease Clinical Trial Failures: Ineffective Drugs or Flawed Clinical Trials?
Discussant: Steven Paul, M.D. Cornell University
10:00 a.m.–11:30 a.m. Frontiers of Science Lecture (Session #L17)Transforming Clinical Outcomes in Addiction Hawaii Convention Center—Kalakaua Ballroom, Level 4
Speaker: Nora D. Volkow, M.D. Director, National Institute on Drug Abuse
MONDAY, M AY 16
P A G E 4 P A G E 5
MONDAY, M AY 16
10:00 a.m.–11:30 a.m. Workshop (Session #W68)Does the Brain Ever Recover From Drug Addiction? Hawaii Convention Center—Room 319A/B, Level 3
Chair: Steven Grant, Ph.D. National Institute on Drug Abuse
Presenters: Jay Nierenberg, M.D., Ph.D. Nathan S. Klein Institute for Psychiatric Research
Diana Martinez, M.D. Columbia University
George Fein, Ph.D. Neurobehavioral Research, Inc.
Marc Potenza, M.D., Ph.D. Yale University
12:00 p.m.–1:30 p.m. Forum (Session #F04)Health Reform: Transforming Addiction Services in the United StatesHawaii Convention Center—Room 310, Level 3
Co-Chairs: Nora D. Volkow, M.D. Director, National Institute on Drug Abuse
Wilson Compton, M.D., M.P.E. National Institute on Drug Abuse
Presenters: Thomas McLellan, Ph.D. University of Pennsylvania Overview of Health Reform and Implications for Addiction Services
H. Westley Clark, M.D., J.D., M.P.H. Substance Abuse and Mental Health Services Administration Electronic Health Records and Privacy Concerns
P A G E 6 P A G E 7
TUESDAY, MAY 17
8:00 a.m.–11:00 a.m. Symposium (Session #S61)Update on the Treatment of Comorbid Opioid Addiction and Chronic Pain Hawaii Convention Center—Room 318, Level 3
Chair: Will M. Aklin, Ph.D. National Institute on Drug Abuse
Presenters: Sean Mackey, M.D., Ph.D. Stanford University Update on the Treatment of Acute and Chronic Pain in the Patient With a History of Addiction
Ian Carroll, M.D. Stanford University A Prospective, Longitudinal, Observational Cohort Study of Pain Duration in Post-Surgical Patients
Declan Barry, Ph.D.Yale University Cognitive–Behavioral Treatment for Co-occurring Chronic Pain and Opioid Dependence
Roger Weiss, M.D. Harvard University Pain and Prescription Opioid Dependence: Secondary Outcomes From NIDA Clinical Trials Network’s Prescription Opioid Addiction Treatment Study
Jennifer Potter, Ph.D. The University of Texas Health Science Center Co-occurring Chronic Pain and Opioid Addiction: Is There a Role for Integrated Treatment?
T UE S DAY, M AY 17
P A G E 6 P A G E 7
T UE S DAY, M AY 17
8:00 a.m.–11:00 a.m. Symposium (Session #S63)Marijuana and Psychosis: Epidemiology, Neuroscience, and Clinical PerspectivesHawaii Convention Center—Room 324, Level 3
Co-Chairs: Wilson Compton, M.D., M.P.E. National Institute on Drug Abuse
Steven Grant, Ph.D. National Institute on Drug Abuse
Presenters: David Fergusson, Ph.D. University of Otago, New Zealand Cannabis Use and Psychosis: Is There a Causal Link?
Nathan Gillespie, Ph.D. Virginia Commonwealth University Exploring the Genetic and Environmental Association Between Cannabis Use and Psychosis
Dean Wong, M.D., Ph.D. Johns Hopkins University Imaging Cannabinoid Receptors in Patients With Schizophrenia Using PET
Joseph Cheer, Ph.D. University of Maryland Endogenous Cannabinoids and the Neurobiological Control of Mental Illness
Discussant: Deepak Cyril D’Souza, M.D. Yale University
P A G E 8 P A G E 9
HAWAII CONVENTION CENTER LEVEL 3 MEETING ROOMS
22
301B 301A
303A
303B
305A
305B
307A
307B
308A
308B
309
318B318A
321A
321B
319B319A
322A322B
323A
323B
323C
324
325A325B
306B
306A
304B
304A
302B
302A
313C
311
312
313A
313B
ALA HALAWAICONCOURSE
PĀ KAMALI`ICOURTYARD
PĀ KALIHICOURTYARD
326B327328
316C
316B
316A
315
314
317A
326A
317B
PĀ KALOKACOURTYARD
PĀ KAMALI`ICOURTYARD
PĀ KALOKACOURTYARD
310
PĀLOLO
MĀNOA
MAKIKI
O`AHU
KAUA`I
NI`IHAU
O`AHU
WAI LANIWATERFALL
KALIAHELUMOAWAIKĪKĪ
MAUI
MAUI
MOLOKA`I
LĀNA`I
KAHO`OLAWE
320 `EMALANITHEATER
LILI`UTHEATER
BALCONY
GRAND STAIRCASEGRAND STAIRCASE
MAIN LOBBY (Level 1)
P A G E 8 P A G E 9
HAWAII CONVENTION CENTER LEVEL 4 MEETING ROOMS
A
B
C
GRAND STAIRCASEGRAND STAIRCASE
EXIT
EXIT
EXIT
(Level 3)
ROOFTOPGARDEN
KĀLAKAUABALLROOM
MĀHEALANIGARDENS
MĀHEALANIGARDENS
ALA WAI TERRACE
BALLROOMFOYER
GREEN ROOM
BALLROOMFOYER
SERV
ICE C
ORRI
DOR
American Psychiatric Association
Annual Meeting
SY
NE
RG
Y E
NT
ER
PR
ISE
S, IN
C.
87
57
GE
OR
GIA
AV
EN
UE
, SU
ITE
14
40
SILV
ER
SP
RIN
G, M
D 2
09
10
NA
TIO
NA
L IN
ST
ITU
TE
S O
F H
EA
LTH
U.S
. DE
PA
RT
ME
NT
OF
HE
ALT
H A
ND
HU
MA
N S
ER
VIC
ES
Advancing PsychiatricPractice Through theScience of AddictionMission StatementExhibitWebsiteSaturday, May 14Sunday, May 15Monday, May 16Tuesday, May 17Hawaii Convention CenterLevel 3 Meeting RoomsLevel 4 Meeting Rooms
